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FINANCING HEALTHY LIVING  
IN THE CZECH REPUBLIC 
Elena Martin
 Due to the wider availability of advanced 
healthcare technologies and services, many 
westernized countries are experiencing 
improved health outcomes. Following the fall 
of the communist regime in 1989, the Czech 
Republic has transitioned into the arena of 
westernized medicine. Two sets of issues have 
arisen during the transition. The healthcare 
system in the Czech Republic is characterized 
by extensive utilization of healthcare goods and 
services but, counter-intuitively, does so with 
an insignificant impact on health outcomes, 
such as life expectancy, mortality as a result 
of cardiovascular disease, and incidence of 
cancer. The Czech Republic operates under a 
nationalized healthcare system, where citizens 
enjoy almost universal free coverage of health-
related expenses. The long-term financial 
sustainability of this system is brought into 
question when considering the extent of 
consumption of healthcare goods and services 
by the general population and the increasing 
average age of citizens in the Czech Republic. If 
the current high levels of utilization continue 
in the future, it is unclear if the healthcare 
system and the national government will be 
able to support the increasing numbers of 
economically inactive citizens. 
 This article argues that an increased 
emphasis on preventative care, public health, 
and improvement of lifestyle factors, such as 
reduced tobacco consumption, would help 
decrease pressures on the healthcare system’s 
financial infrastructure and lead to long-
term improved health outcomes throughout 
the Czech Republic. Currently, 2.1 percent 
of the Czech Republic’s total expenditure on 
healthcare is allocated to prevention and public 
health (Eurostat, 2012). Allocating a larger 
percentage of funds toward the development of 
disease prevention and public health programs 
could decrease the burden of long-term 
chronic illness treatment that is financially 
taxing on a healthcare system. In addition, 
these programs could work to remedy some of 
the negative health outcomes currently facing 
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the nation and thereby improve overall health 
in the Czech Republic. 
Historical Background
 Modern healthcare in the Czech Republic 
was born out of a rigid centralized system 
implemented under the Soviet Union. This 
system, termed the Semashko model, was 
completely state owned and controlled and 
was defined by universal access to healthcare 
throughout the country. Government mandates 
controlled all aspects of healthcare: delivery 
of service, infrastructure, and employment 
of workers. Therefore, it was often tainted by 
political motivations instead of patient needs. 
Even though the system was fraught with 
political undertones, the Semashko model 
was highly effective in delivering healthcare 
services to fit the needs of the nation. Citizens 
throughout the country were able to access 
healthcare facilities and receive care from 
a physician at both hospitals and clinics at 
no direct charge to the patient. Under the 
Semashko model, infant mortality rates and 
rates of tuberculosis infection decreased. As 
time progressed, however, it became more and 
more evident that there was a growing need 
for a more flexible system that could adapt to 
the changing needs of the country. The rigid 
Semashko model was unable to adapt to health 
problems created by changes in lifestyle factors 
and environmental conditions (Kinkorová and 
Topolčan, p. 3). 
Establishment of the Modern System
 Following the split of Czechoslovakia into 
the Czech Republic and Slovakia on January 1, 
1993, the newly born Czech nation developed 
its own system of healthcare, transitioning to 
an insurance-based model of healthcare. While 
there is certainly evidence of the Semashko 
model in the modern system (e.g., universal 
healthcare coverage), there has been a 
transition to increased patient autonomy. Under 
the modern healthcare system, economically 
active citizens, comprising approximately 42 
percent of the population, make an obligatory 
contribution to the Social Health Insurance 
Fund at a rate of 4.5 percent of their annual 
income. Economically active citizens are 
defined as all persons who furnish labor supply 
for the production of economic goods and 
services (OECD, 2002). This flat tax rate has 
no cap. Employers also make contributions 
of 9 percent of all of their employees’ gross 
salaries (CzechInvest). Economically inactive 
citizens, comprising the remaining 58 percent 
of the population, include the unemployed, 
incarcerated individuals, students, men and 
women on parental leave, individuals serving 
in the military, individuals seeking asylum, and 
those receiving social security benefits (i.e., the 
elderly). For economically inactive citizens, the 
government makes contributions to the Social 
Health Insurance Fund on their behalf (Alexa et 
al., p. 15). The revenue for state contributions to 
the Social Health Insurance Fund comes from 
general national taxation funds. All individuals 
have the ability to choose from among a 
number of nationalized health insurance 
companies for coverage. Because insurance 
companies are public, they are prohibited from 
denying anyone coverage, which guarantees 
health coverage to all individuals throughout 
the country, regardless of their employment 
status. Currently, there are seven health 
insurance funds in the Czech Republic, the 
largest being Všeobecná Zdravotní Pojišťovna, 
or the General Health Insurance Company, 
which covers approximately 60 percent of the 
population. All the insurance funds offer the 
same baseline level of coverage and differ only 
slightly in terms of special coverage options. 
For example, all personnel serving in the Czech 
military are covered under the same health 
insurance fund. 
Overview of Comparison Nations
 Comparative data from selected nations 
within the Organisation of Economic Co-
operation and Development (OECD) provide 
perspective on the Czech healthcare system. 
Although the OECD is comprised of 34 
democratic states with market economies as 
well as 70 supporting states, the summary 
data are based on only the current 34 member 
states, with individualized data from six 
regional comparator nations including the 
Czech Republic. Comparator nations include 
Austria, Czech Republic, Germany, Poland, 
Slovakia, and Slovenia. These nations are 
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examined for several indicators of quality of 
healthcare, healthcare outcomes, and usage 
of care. In this article, comparator nations 
were chosen on the basis of their geographic 
proximity to the Czech Republic, in addition to 
similarities in their healthcare system model. 
In order to gain a well-rounded comparison to 
Czech figures, OECD averages and the average 
of the comparator nations also are considered. 
 As seen in Table 1, comparator nations 
spend roughly between 6.4 percent (Poland) 
and 11 percent (Germany) of GDP on 
healthcare. The Czech Republic falls toward the 
lower end of the range, spending 7.1 percent 
on healthcare, which is significantly below the 
OECD average of 8.9 percent. 
  In addition to considering the percentage 
of GDP allocated to financing total healthcare 
expenditures, it is important to consider how 
those funds are distributed across major 
areas of healthcare spending. There is a trend 
among many westernized countries to expend 
significant amounts of funding on complicated 
end-of-life procedures that oftentimes provide 
little additional life expectancy benefit and 
that only marginally improve quality of 
life. In the case of the Czech Republic, it is 
especially important to look at spending on 
prevention and public health services. For all 
comparator countries, only a small percentage 
of total healthcare spending is designated for 
prevention and public health. 
 Currently in the Czech Republic, the 
primary provider and overseer of public 
health is the National Institute of Public 
Health, Státní Zdravotní Ústav (SZU), which 
is supplemented by 14 regional public health 
authorities. SZU provides epidemiological 
surveillance, conducts research, and monitors 
environmental health factors as well as the 
implementation of European Union (EU) 
regulations and standards. A major role of 
the SZU is the provision of preventative care 
covered under the social health insurance 
fund. Preventative services provided include 
nationwide compulsory vaccination programs 
for children as well as physical examinations 
with a pediatrician; biannual examinations 
with a general practitioner and compulsory 
vaccinations for adults; cancer screening 
programs for colorectal, breast, and cervical 
cancers; biannual mammographies for women 
aged 45 to 69; gynecological examinations of 
women beginning at age 15; and population-
wide vaccinations against a wide range of 
diseases, including diphtheria, cervical 
cancer, hepatitis B, Haemophilus influenzae 
type B, measles, mumps, rubella, pertussis, 
poliomyelitis, tetanus, and tuberculosis 
(Kinkorová and Topolčan, p. 6). While these 
Table 1
Healthcare Expenditure as a Percentage of 2015 Total Gross Domestic Product
Country
Percentage of  
GDP Expended  
on Healthcare
Austria  10.1
Czech Republic  7.1 
Germany  11.0 
Poland  6.4 
Slovakia  7.6 
Slovenia  8.7 
Cohort average  8.5 
OECD average  8.9
Source: OECD (b). 2013.
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services are invaluable in terms of identifying 
and preventing many diseases, the system 
currently in place does little to tackle the social 
determinants of health which are currently 
playing a significant role in determining 
the health outcomes of the Czech Republic 
(Kinkorová and Topolčan, p. 6).
 Preventative medicine is a specialty 
practice of medicine that focuses on enhancing 
individual and community health with the goal 
of preventing disease, disability, and death. 
This proactive approach to medicine hopes 
to prevent disease rather than retroactively 
treat advanced conditions. Given the current 
status of healthcare in the Czech Republic, an 
emphasis on preventative medicine could have 
an impact by addressing lifestyle maladies, 
such as excessive consumption of tobacco 
and alcohol and the increased incidence rate 
of obesity, as well as having long-term effects 
on aging populations, thereby decreasing the 
burden on healthcare infrastructure. Some 
characteristics of preventative medicine 
include the focus on educational programs 
targeted at specific areas of community health 
and an emphasis on individual patient care. 
An emphasis on individual patient care is 
especially important because it targets each 
patient’s specific conditions to broadly improve 
the patient’s overall health. This could mean 
managing hypertension and high cholesterol 
with medication in addition to lifestyle 
alterations such as avoiding foods with high 
sodium content. 
 As seen in Table 2, preventative 
healthcare measures account for only 1.8 
percent (Austria) to 4.0 percent (Slovenia) of 
total healthcare expenditure, with the Czech 
Republic again falling toward the lower end 
of the range with 2.1 percent. This is less than 
the comparator nation average of 2.7 percent. 
Data for Table 2 come from Eurostat: Statistics 
Explained; therefore, an OECD average is 
not considered for this table. Both Tables 1 
and 2 indicate that financial expenditures on 
healthcare, and specifically financial resources 
available for prevention and public health in 
the Czech Republic, are limited. Changes in 
the allocation of financial resources have the 
potential to have a significant impact on health 
outcomes in the Czech Republic. 
Access to Care
 Two indicators of the availability of and the 
timely access to healthcare resources are the 
number of practicing physicians throughout 
the nation and the number of available hospital 
beds. Especially in nationalized healthcare 
systems, a shortage of physicians often means 
long wait times to receive care; and a shortage of 
hospital beds means difficulty treating patients 
in a timely manner. This is not an issue in the 
Czech Republic, although regional disparities 
in physician density do exist. For example, 
the city of Prague has the highest number 
of practicing physicians, which correlates 
with it having the highest population density 
in the Czech Republic. Nonetheless, due to 
deliberate actions by insurance funds and the 
government, there is good access to medical 
care throughout the nation, even in the most 
rural areas. 
 As seen in Figure 1, the Czech Republic 
has 3.67 physicians per thousand people in 
the population, greater than both the OECD 
average of 3.1 physicians per thousand people 
and the cohort average of 3.2 physicians per 
thousand people. Figure 2 shows the number 
of hospital beds available per thousand people. 
In the Czech Republic, hospital beds refer 
to all available beds in a hospital including 
those for newborn babies. This latter category 
is not included in all OECD countries’ 
data; nevertheless, this is a relatively small 
percentage that does not affect the overall 
results dramatically. In both Figures 1 and 
2, the Czech Republic has values above the 
OECD and cohort averages, which indicate 
that negative health outcomes are likely not 
attributable to lack of access to quality medical 
care.
Overall Consumption of Healthcare 
Goods and Services
 Overconsumption of healthcare services 
and products (physician consultations, 
pharmaceuticals, etc.) has been a defining 
characteristic of the Czech healthcare system. 
Given its status as a nationalized health system, 
there is no limitation to the number of visits 
an individual can have; and with the exception 
of elective procedures, all visits are covered 
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Table 2
Healthcare Expenditure by Function (As Percent of Total Health Expenditure), 2012
Comparator
Country
Services of 
Curative and 
Rehabilitative
Care
Services of
Long-
Term 
Nursing 
Care
Ancillary
Services to 
Healthcare
Medical 
Goods 
Dispensed 
to 
Outpatients
Prevention
and 
Public
Health 
Services
Health 
Administration
and Health
Insurance
Not
Specified
Austria 60.2 14.5 3.2 16.5 1.8 3.8 N/A
Czech 
Republic
60.1 3.9 5.7 24.5 2.1 3.0 0.6
Germany 54.5 12.6 4.8 19.4 3.3 5.4 N/A
Poland 60.1 7.0 5.1 24.6 2.0 1.2 N/A
Slovakia 46.9 0.3 8.5 38.0 2.8 3.5 N/A
Slovenia 56.5 8.9 3.4 23.8 4.0 3.5 N/A
Cohort 
average
56.4 7.9 5.1 24.5 2.7 3.4 N/A
Source: Eurostat: Statistics Explained. 
Figure 1
Physician Density per 1,000 People, 2013
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  Source: OECD. 2013.
  Note: Data for Slovakia were taken from the 2007 database due to the lack of availability of more current data.
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by the national health insurance companies. 
This has led to a significant consumption of 
healthcare services and related goods (e.g., 
pharmaceuticals and home care equipment) in 
the Czech Republic. According to the OECD, in 
2013 the average Czech had 11.1 consultations 
with a physician (see Figure 3) and 2.4 
outpatient hospital consultations.1 These are 
compared to the OECD averages of 7.81 and 
1.8, respectively. 
 In 2008, a user fee system was 
implemented as a mechanism to decrease 
the consumption of healthcare goods and 
services (van Ginneken et al., p. 2). Although 
there was a slight decrease in consumption 
after the implementation of user fees from the 
2006 number of 15.0 visits per capita, the per 
capita average consumption is still far above 
OECD averages. Large numbers of physician 
consultations can lead to stress on healthcare 
infrastructure as well as a breakdown in 
efficiency. 
 User fees were initially set at what were 
deemed moderate rates: Czech koruny (CZK) 
30 (€1.20) per physician consultation, CZK 
60 (€2.40) per day of stay in a hospital, CZK 
30 (€1.20) for prescribed pharmaceuticals, 
and CZK 90 (€3.60) for ambulatory care (van 
Ginneken et al., p. 2). It is necessary to note 
that individuals belonging to vulnerable 
populations, such as neonates, chronically ill 
children, pregnant women, those living below 
the poverty line, those with diagnosed infectious 
diseases, and those receiving preventative care, 
were exempt from participation in the user 
fee system. The implementation of user fees 
has proved an extremely controversial topic 
in the Czech Republic. Following political 
unrest in 2009, it was decided that fees would 
be reduced for the young and for the elderly. 
One of the largest concerns regarding the 
implementation of user fees is the financial 
and administrative pressure it puts on regional 
authorities responsible for reimbursements. 
The decision to implement a user fee system 
has also created political divisions. Ultimately, 
due to a lack of political consensus on the 
efficacy of the user fee system, control over 
 1Figures for outpatient hospital consultations are 
not included due to a lack of available data for all cohort 
nations. 
the implementation of the user fee system fell 
on regional health authorities. Furthermore, 
inconsistent implementation of the user fee 
system has led to individuals seeking medical 
care traveling to certain regions of the Czech 
Republic in which the user fee system is not 
currently in place. There has been concern 
that the regional implementation differences 
will have an impact on the equity in access 
to care, although there has been no evidence 
of this thus far. To decrease financial and 
administrative stress on regional health 
authorities and hospitals, the user fee system 
must be implemented consistently throughout 
the country or not at all. Additionally, there 
may be strategies available, such as increased 
spending on prevention and public health, that 
would decrease the number of annual physician 
consultations per capita without causing the 
level of political controversy observed under 
the implementation of the user fee system. 
 In addition to extensive consumption of 
physician consultations, the Czech Republic 
has a high consumption of prescription 
pharmaceuticals compared to most other 
OECD nations. The immediate cause of high 
consumption is currently unclear, although 
it has been speculated that patients may lack 
confidence in their physicians and therefore 
simply request prescriptions as a solution to 
their illness. Or it could be that physicians are 
not confident in themselves and are therefore 
concerned about the possibility of lawsuits and 
are quick to prescribe pharmaceuticals as a 
more simplistic treatment of an illness. Zeno 
Veselik, Executive Director of ABC Works, 
suggests that physicians may be more apt 
to prescribe pharmaceutical products when 
they are receiving some financial benefit from 
pharmaceutical companies. In addition to 
over-prescribing, it was estimated in 2006 that 
from CZK 4 billion to CZK 10 billion worth of 
drugs prescribed went unused (van Ginneken 
et al., p. 2). Although the reasons for this 
behavior are unknown, it is clear that unused 
pharmaceuticals prove to be a financially 
stressing aspect of the Czech healthcare system. 
Whatever the reasons, according to the OECD, 
21.1 percent of total health expenditure in the 
Czech Republic was spent on pharmaceuticals 
in 2012. In order to maintain the financial 
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Figure 2
Number of Hospital Beds per 1,000 People, 2012
Source: OECD. 2012. 
Figure 3
Annual Physician Consultations per Capita, 2013
Source: OECD (a). 2013.
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stability and efficiency of the Czech health 
system, serious consideration needs to be given 
to strategies to control consumption. 
Measures of Overall Health in the 
Czech Republic
 Life expectancy in the Czech Republic is 
75.8 years for men and 82.0 years for women 
compared with OECD averages of 77.5 years and 
82.5 years, respectively (Eurostat Core Public 
Health Data, 1989; Eurostat Core Public Health 
Data, 2014). This ranks the Czech Republic 
28th of 34 OECD member countries in terms 
of life expectancy. There are numerous factors 
that can have an impact on life expectancy, 
the quality of and access to health systems 
being just one. Lifestyle factors, such as diet, 
alcohol consumption, smoking, environmental 
conditions, and national security, also can 
have an impact on life expectancies. In an 
OECD study, two health outcomes gave strong 
indications about the status of health in the 
Czech Republic. Of the 34 nations studied, 
the Czech Republic has the fourth highest 
mortality rate from cardiovascular disease 
and the seventh highest mortality rate from 
cancer (OECD, 2014). This raises the question 
of why Czechs, who are visiting a physician 
approximately once a month, appear to have 
shorter life expectancies and higher rates of 
morbidity from cardiovascular disease and 
cancer than what otherwise might be expected. 
Access to healthcare does not appear to be the 
cause of such negative health outcomes. 
 The top ten causes of death in the Czech 
Republic according to the World Health 
Organization are coronary heart disease (24.95 
percent of all deaths); stroke (9.7 percent); 
trachea, bronchus, and lung cancers (5.7 
percent); colon and rectal cancers (3.8 percent); 
lower respiratory infections (2.8 percent); 
chronic obstructive pulmonary disease (2.4 
percent); diabetes mellitus (2.2 percent); 
hypertensive heart disease (2.1 percent), 
pancreatic cancer (2.1 percent); and cirrhosis 
of the liver (1.8 percent) (World Health 
Organization, 2012). According to the World 
Heart Federation, risk factors for coronary 
heart disease are tobacco use, diets high in 
saturated fats, obesity, and physical inactivity. 
Similarly, important risk factors for stroke are 
hypertension and tobacco consumption (World 
Heart Federation). The American Cancer 
Society cites smoking as the single highest 
risk factor for the development of lung cancer, 
in addition to several other conditions, such 
as lower respiratory infections and chronic 
obstructive pulmonary disease (American 
Cancer Society [b], 2016). Additionally, diets 
high in processed meats, cooking meat at very 
high heat, and obesity are listed as risk factors 
for colon and rectal cancer (American Cancer 
Society [a], 2016). 
 When looking at these top ten causes 
of death as determined by the World Health 
Organization, there appears to be a correlation 
between lifestyle risk factors and ultimate 
cause of death. In the Czech Republic, the 
factors playing the most significant role in 
the overall health of the nation are the non-
medical determinants of health; these include 
tobacco consumption, alcohol consumption, 
nutrition (especially the consumption of 
processed meats), and body weight. 
 Tobacco consumption is internationally 
recognized as one of the highest contributors 
to negative health outcomes (World Health 
Organization, 2016). In addition to the 
highly addictive nature of ingredients such 
as nicotine, tobacco products contain what 
seems to be an endless list of chemicals. 
These chemicals include carcinogens, such 
as tar, formaldehyde, ammonia, arsenic, and 
dichlorodiphenyltrichloroethane (DDT). 
Tobacco consumption is particularly high in 
the Czech Republic, where, as of 2013, 22.2 
percent of the population over the age of 15 
were daily smokers (OECD [b], 2014). With 
approximately one-fifth of the population being 
daily smokers, the impacts to their health, as 
well as the impacts of secondhand smoke to 
others, are significant. While walking through 
the streets of Prague or sitting at a restaurant, 
one can expect to be surrounded by a cloud of 
smoke. Currently there does not appear to be 
any social stigma associated with smoking in 
the Czech Republic. 
 In June 2012, the Czech Republic ratified 
the World Health Organization Framework 
Convention on Tobacco Control, designed 
with the intention of combating the tobacco 
consumption epidemic occurring worldwide. 
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This document outlines signatory nations’ 
commitments to prioritize the maintenance of 
high standards of public health. It is intended 
to tackle the environmental, social, and health-
related impacts of exposure to tobacco smoke, 
whether firsthand or secondhand. In addition 
to the Czech Republic ratifying this treaty, 
there are bans in place throughout the country 
on tobacco advertising and bans on promotion 
on television and on radio broadcasts. Hope 
for future reductions in the consumption of 
tobacco occurred in June 2015 when a bill 
that bans smoking in all restaurants passed 
the legislature. This major step is one in the 
direction of decreasing the effects of smoking 
and secondhand smoke in public areas. It is 
clear that action is being taken by the Czech 
government to decrease tobacco consumption 
nationally. However, given the lack of evidence 
of any decrease in overall tobacco consumption 
levels, broader steps may be necessary to 
influence the consumption of tobacco products. 
These may include prohibiting smoke in all 
indoor public areas, stricter restrictions on the 
sale of tobacco products to minors, and greater 
emphasis on public health campaigns on the 
health risks of tobacco consumption. 
Impacts of an Aging Population 
 As with many westernized countries, 
the Czech Republic is experiencing an aging 
population. In 2015 the average age of a Czech 
person was 41.5 years and is projected to 
increase to 43.4 years by the year 2020 (United 
Nations, 2015). In addition, according to OECD 
demographic statistics, 17.3 percent of the 
Czech population is over the age of 65; and, if 
current trends in population aging continue, 
this percentage will only continue to grow 
in the future. This current age structure can 
be attributed to decreasing rates of fertility, 
combined with increased longevity. This 
increased longevity can be attributed to better 
medical technology and increased availability 
of high-quality medical services. Since the 
Velvet Revolution in 1989, the average life 
expectancy for women has increased from 75.5 
years to 82.0 years and for men from 68.2 years 
to 75.8 years (Eurostat Core Public Health 
Data, 1989; Eurostat Core Public Health Data, 
2014).
 The change in age structure of the 
population impacts many aspects of the 
Czech economy, including healthcare costs. 
A major consequence of an aging population 
is an increased number of economically 
inactive citizens, requiring financial support 
by economically active citizens. By the 
nature of the structure of the Czech health 
insurance plan, only individuals who are 
currently employed contribute to the national 
health insurance fund; all other individuals, 
including those who are retired, have their 
expenses covered by the national government. 
Therefore, with an aging population come 
more individuals retiring each year, and 
relatively fewer younger employees entering 
the work force. This translates into increased 
medical costs for the government, and 
increased consumption of healthcare services, 
accompanied by a dwindling economic base.
 In addition to the increased financial 
burden on the healthcare infrastructure, 
lifestyle determinants of health such as tobacco 
consumption, alcohol consumption, and poor 
diet become more important in old age and 
can exacerbate previously existing medical 
conditions. Therefore, as the Czech population 
ages, it is becoming of even greater importance 
to address the population-wide lifestyle factors 
contributing to negative health outcomes 
throughout the country. 
Conclusion
 The healthcare system in the Czech 
Republic can currently be characterized by 
relatively low levels of expenditure in terms 
of percentage of national GDP. The Czech 
Republic expends 7.1 percent of its total GDP 
on healthcare (OECD [a], 2013). This sits 
below the OECD average of 8.9 percent. This 
expenditure, combined with exceptionally high 
rates of utilization of health care resources, 
such as physician consultations and hospital 
visits, along with an aging population, raises 
the question of the long-term financial 
stability of the current healthcare system in 
the Czech Republic. In addition to finances, it 
is necessary to look critically at the negative 
health outcomes facing the nation. High 
mortality rates from cardiovascular disease and 
cancer suggest that change is needed within 
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the healthcare system to reduce burdens 
on infrastructure and healthcare personnel 
treating these conditions. 
 To resolve this mix of health outcomes and 
financial burden issues, this article suggests 
a multipronged effort. First, increasing 
healthcare expenditure as a percentage of total 
GDP will make more healthcare resources 
available to support the growing number of 
individuals whose healthcare costs are covered 
by the Czech government. Ideally, this level 
should at least match the OECD average of 8.9 
percent of total GDP. Increasing the relative 
percentage allocations for prevention and public 
health services will better address lifestyle 
factors contributing to the high mortality 
rates. By controlling tobacco consumption, 
obesity, and alcohol consumption, the Czech 
Republic will be able to improve its health 
outcomes over time. In addition, targeting 
improvements in lifestyle factors, such as diet 
and exercise as well as a reduction in smoking, 
which widely exacerbates health conditions as 
the population ages, will lead to more efficient 
use of healthcare resources. Another option for 
improving financial efficiency is to implement 
an upper limit on the number of free physician 
consultations annually that are covered by the 
social health insurance funds. Exceptions could 
be made for individuals with chronic health 
conditions requiring regular monitoring by a 
health care professional. Educational programs 
targeted at awareness of over-prescribing 
of drugs could benefit both physicians and 
patients, while at the same time reducing 
financial burdens. Also, just as restrictions 
on television advertising of tobacco products 
can decrease consumption, decreasing the 
number of pharmaceuticals commercials 
could have a similar effect. Taken together, this 
multipronged approach will both decrease the 
prevalence of negative health outcomes while 
simultaneously relieving the financial burden 
on the Czech healthcare system. 
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